QC solution for Qiagen Plasmid prep
- Known as:
- QC buffer Qiagen Plasmid preparation kit
- Catalog number:
- BQ003
- Product Quantity:
- 1000ml
- Category:
- -
- Supplier:
- Intron
- Gene target:
- solution for Qiagen Plasmid prep
Related genes to: QC solution for Qiagen Plasmid prep
- Gene:
- PREP NIH gene
- Name:
- prolyl endopeptidase
- Previous symbol:
- -
- Synonyms:
- -
- Chromosome:
- 6q21
- Locus Type:
- gene with protein product
- Date approved:
- 1996-03-12
- Date modifiied:
- 2016-10-05
Related products to: QC solution for Qiagen Plasmid prep
Related articles to: QC solution for Qiagen Plasmid prep
- Chemical, biological, radiological, and nuclear (CBRN) incidents present escalating risks across the Middle East and North Africa (MENA) amid geopolitical instability, cross-border threats, and evolving non-state actor capabilities. This policy analysis examines why prevailing case-level and ministry-siloed governance is insufficient for population-level CBRN readiness, weighs alternative coordination models, and outlines an artificial intelligence (AI)-enabled, centrally coordinated public-health strategy adapted to the region's heterogeneity and resource constraints. We propose a National Emergency Management Advisory Council to provide statutory inter-ministerial authority and stewardship for a National CBRN Dashboard that delivers decision support, inventory tracking, simulation, and rapid triage. We situate this within existing backgrounds and analyze legal authority, financing, data governance, and feasibility in low-resource settings. While prototype AI models report high accuracy for antidote optimization, agent classification, and triage, we argue these metrics reflect controlled research, not operational readiness, and require external validation, robustness testing, and cybersecurity safeguards. A phased, evidence-graded roadmap is proposed to move MENA CBRN management from reactive to predictive and adaptive models. - Source: PubMed
Publication date: 2026/08/05
Farhat HassanTin DerrickShin HeejunAl-Ali Saleh FaresMochrie DarenMorris BrendonCiottone Gregory - Despite progress in antiretroviral therapy and prevention, HIV remains a major public health challenge in Spain. Pre-exposure prophylaxis (PrEP) is a proven and effective prevention strategy, but challenges in access, equity, adherence and persistence limit its population impact. Our aim was to identify current barriers to PrEP adoption in Spain and develop actionable solutions. We conducted a structured consensus process (September 2024-May 2025) with 19 experts from fields including infectious diseases/HIV care, sexual health/sexually transmitted infection services, primary care, emergency medicine, nursing, pediatrics, hospital pharmacy, public health, epidemiology/biostatistics, and community-based organizations. It included semi-structured interviews, multidisciplinary small-group sessions, and two plenary workshops. Complementary descriptive surveys of healthcare professionals (HCPs) and NGO/community health centers ( = 150) and current/potential/past PrEP users ( = 95) provided contextual data. Consensus statements were developed using a facilitator-led approach based on nominal group techniques, with community representatives contributing lived-experience insights. The panel identified key challenges, including fragmented access (hospital-centered), capacity constraints, restrictive eligibility criteria, knowledge gaps, adherence and persistence issues, and limitations in information systems. To address these, a focused decalogue was developed to promote decentralization, equity, person-centered care and preparedness for transformative innovation in PrEP. The ComPrEmetidos consensus offers an operational roadmap to move Spain from policy availability to program performance and more effectively reduce new HIV infections in Spain. Priorities include decentralization, improving the training and knowledge of HCPs and the general public, rapid linkage to PrEP, and the incorporation of innovation, especially for those for whom oral PrEP is not sufficient. - Source: PubMed
Publication date: 2026/08/05
Jarrín InmaculadaFernandez NuriaGarrido JorgeLópez LuisPolo Rosa - Methamphetamine use is associated with HIV risk behaviors, seroconversion, and suboptimal daily, oral PrEP adherence among men who have sex with men (MSM). Long-acting pre-exposure prophylaxis (PrEP) formulations, such as bimonthly cabotegravir (CAB) and biannual lenacapavir (LEN) injections, may be particularly effective for HIV prevention in this population. We conducted interviews with 17 individuals in the western US who provided a service in the past month to an HIV-negative man who has sex with men and uses methamphetamine. Interviews were audio recorded and transcribed. Interviews inquired about barriers to each step of the PrEP cascade and strategies to overcome them. Transcriptions were coded by at least two analysts and reconciled. Interviews revealed several barriers to long-acting PrEP engagement among MSM who use methamphetamine across the cascade, most notably homelessness, which included competing priorities and inconsistent phone access. Despite the identification of housing instability as a barrier to long-acting PrEP engagement, it was also cited as a reason why long-acting PrEP may be particularly promising for MSM who use methamphetamine. Anticipated stigma was also identified as a primary barrier to long-acting PrEP engagement. Provider-level barriers were described, including overburdened clinics, limited hours, requisite staffing expertise, and billing restrictions. Strategies to increase long-acting PrEP provision among this population who could benefit from PrEP included reducing provider-side barriers and integrating long-acting PrEP with other appealing services (e.g., syringe services programs), extended hours, mobile delivery, and contingency management. - Source: PubMed
Publication date: 2026/08/05
McMahan Vanessa MPope EmilyLuna Marti XochitlLiu Albert YCoffin Phillip O - Colorectal cancer is a leading cause of cancer-related deaths in the United States, and colonoscopy remains the gold standard for early detection and prevention. However, many procedures are postponed due to inadequate bowel preparation, a preventable failure often caused by patients' difficulty in understanding and following written prep instructions. Prior interventions such as reminder apps and instructional videos have improved adherence only modestly, largely because they cannot answer patient-specific questions. Recent advances in large language models (LLMs) raise the possibility of developing conversational assistants that can provide interactive support to patients in procedure preparation. - Source: PubMed
Publication date: 2026/08/04
Kaumenova TomirisChakraborty SubhankarFosler-Lussier EricGofar KebireMetcalf IsaiahPerrault AndrewWhite Michael - Plant polysaccharides have attracted considerable interest in natural product research due to their immunomodulatory, antitumor, and hypoglycemic activities. The development of efficient and gentle extraction and purification techniques is crucial for obtaining highly pure bioactive polysaccharides. This review systematically covers recent progress in extraction methods, including conventional hot water (simple but time‑consuming), acid/alkali (high yield but structure‑damaging), enzyme‑assisted, and physical field‑assisted techniques such as ultrasound and microwave, which provide higher efficiency under gentler conditions. For purification, a comparative analysis was conducted on the advantages and limitations of physical/chemical and biological methods for purifying polysaccharides. Furthermore, the review addresses current challenges, such as limited selectivity and throughput, and explores future directions, including the adoption of green solvents, intelligent process control, and integrated extraction-purification-evaluation platforms, with the objective of facilitating standardized production and high-value utilization. - Source: PubMed
Publication date: 2026/08/04
Qi RulanDing BeibeiFang MingyangXiao ShenshengWang Xuedong